Fourth biannual report of the Cochrane Haematological Malignancies Group

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bleomycin / administration & dosage
• Boronic Acids / administration & dosage
• Bortezomib
• Cyclophosphamide / administration & dosage
• Dexamethasone / administration & dosage
• Doxorubicin / administration & dosage
• Etoposide / administration & dosage
• Europa
• Hematologic Neoplasms / drug therapy*
• Hematologic Neoplasms / therapy
• Humans
• Lymphoma, B-Cell / drug therapy
• Lymphoma, Follicular / drug therapy
• Lymphoma, Large B-Cell, Diffuse / drug therapy
• Lymphoma, Mantle-Cell / drug therapy
• Lymphoma, Non-Hodgkin / drug therapy
• Meta-Analysis as Topic
• Multicenter Studies as Topic
• Multiple Myeloma / drug therapy
• National Institutes of Health (U.S.)
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
• Prednisone / administration & dosage
• Procarbazine / administration & dosage
• Pyrazines / administration & dosage
• Randomized Controlled Trials as Topic
• Rituximab
• Stem Cell Transplantation
• Transplantation, Autologous
• Vereinigte Staaten
• Vinblastine / administration & dosage
• Vincristine / administration & dosage